Executive function, social roles and physical function loom large in new study
Phase 3 EXPAND trial suggests potential utility of siponimod
Novel monoclonal antibody takes aim at alpha-synuclein clusters
Most substantial reversal of amyloid deposition in an animal study to date
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
CSCs achieve timelier acute reperfusion therapy, national study finds
DEFUSE 3 results support lengthening treatment window in imaging-selected patients
One-year stroke mortality rate down by 18 percent over five years
First new medical intervention in a decade to demonstrate improved survival
Does the clinical benefit manifest electrophysiologically?
Advances toward biomarkers of progression are underway
Advertisement
Advertisement